Literature DB >> 20408892

Cholinergic stimulation of the immune system protects against lethal infection by Salmonella enterica serovar Typhimurium.

Maria J Fernandez-Cabezudo1, Dietrich E Lorke, Sheikh Azimullah, Milena Mechkarska, Mohammed Y Hasan, Georg A Petroianu, Basel K al-Ramadi.   

Abstract

SUMMARY: The cholinergic nervous system has been demonstrated to attenuate the inflammatory response during sepsis via the inhibitory action of acetylcholine (ACh) on macrophages. These findings were largely based on experimental sepsis models using endotoxin as the inducing agent. Herein, however, we report that the specific inhibition of acetylcholinesterase (AChE) renders animals more resistant to infection by a virulent strain of Salmonella enterica serovar Typhimurium, a Gram-negative enteric pathogen. Inhibition of AChE was induced by a subchronic exposure to paraoxon, a potent anti-cholinesterase metabolite of the organophosphorous compound parathion. Our findings indicate that inhibition of AChE enhanced survival of infected mice in a dose-dependent fashion and this correlated with efficient control of bacterial proliferation in target organs. Immunologically, inhibition of AChE enabled the animals to mount a more effective inflammatory anti-microbial response, and to secrete higher levels of interleukin-12, a key T helper type 1-promoting cytokine. The ACh-induced enhancement in resistance to infection was abrogated by co-administration of an oxime which can reactivate AChE. Hence, in a model of Gram-negative bacterial infection, cholinergic stimulation is shown to enhance the anti-microbial immune response leading to effective control of bacterial proliferation and enhanced animal survival.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20408892      PMCID: PMC2913218          DOI: 10.1111/j.1365-2567.2009.03238.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  53 in total

Review 1.  The vagus nerve as a modulator of intestinal inflammation.

Authors:  E P Van Der Zanden; G E Boeckxstaens; W J de Jonge
Journal:  Neurogastroenterol Motil       Date:  2009-01       Impact factor: 3.598

2.  The organophosphate paraoxon has no demonstrable effect on the murine immune system following subchronic low dose exposure.

Authors:  M J Fernandez-Cabezudo; S Azimullah; S M Nurulain; M Mechkarska; D E Lorke; M Y Hasan; G A Petroianu; B K Al-Ramadi
Journal:  Int J Immunopathol Pharmacol       Date:  2008 Oct-Dec       Impact factor: 3.219

Review 3.  Pyridinium oxime reactivators of cholinesterase inhibited by diisopropyl-fluorophosphate (DFP): predictive value of in-vitro testing for in-vivo efficacy.

Authors:  G A Petroianu; D E Lorke
Journal:  Mini Rev Med Chem       Date:  2008-11       Impact factor: 3.862

4.  Natural killer cells mediate protection induced by a Salmonella aroA mutant.

Authors:  R Schafer; T K Eisenstein
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

5.  Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent.

Authors:  P I Fields; R V Swanson; C G Haidaris; F Heffron
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells.

Authors:  P Mastroeni; B Villarreal-Ramos; C E Hormaeche
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

7.  Early parasite containment is decisive for resistance to Leishmania major infection.

Authors:  T Laskay; A Diefenbach; M Röllinghoff; W Solbach
Journal:  Eur J Immunol       Date:  1995-08       Impact factor: 5.532

8.  IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.

Authors:  T Scharton-Kersten; L C Afonso; M Wysocka; G Trinchieri; P Scott
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

9.  Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection.

Authors:  T K Eisenstein; L M Killar; B M Sultzer
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

10.  Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo.

Authors:  A Richter-Dahlfors; A M Buchan; B B Finlay
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

View more
  12 in total

1.  S. Typhimurium challenge in juvenile pigs modulates the expression and localization of enteric cholinergic proteins and correlates with mucosal injury and inflammation.

Authors:  Calvin S Pohl; Elizabeth M Lennon; Yihang Li; Morgan P DeWilde; Adam J Moeser
Journal:  Auton Neurosci       Date:  2018-06-08       Impact factor: 3.145

2.  Caffeine intake may modulate inflammation markers in trained rats.

Authors:  Rômulo Pillon Barcelos; Mauren Assis Souza; Guilherme Pires Amaral; Silvio Terra Stefanello; Guilherme Bresciani; Michele Rechia Fighera; Félix Alexandre Antunes Soares; Nilda de Vargas Barbosa
Journal:  Nutrients       Date:  2014-04-21       Impact factor: 5.717

3.  The M3 muscarinic receptor is required for optimal adaptive immunity to helminth and bacterial infection.

Authors:  Matthew Darby; Corinna Schnoeller; Alykhan Vira; Fiona Jane Culley; Fiona Culley; Saeeda Bobat; Erin Logan; Frank Kirstein; Jürgen Wess; Adam F Cunningham; Frank Brombacher; Murray E Selkirk; William G C Horsnell
Journal:  PLoS Pathog       Date:  2015-01-28       Impact factor: 6.823

4.  Signals of vagal circuits engaging with AKT1 in α7 nAChR+CD11b+ cells lessen E. coli and LPS-induced acute inflammatory injury.

Authors:  Caiqi Zhao; Xi Yang; Emily M Su; Yuanyuan Huang; Ling Li; Michael A Matthay; Xiao Su
Journal:  Cell Discov       Date:  2017-04-11       Impact factor: 10.849

5.  Cholinergic Stimulation Prevents the Development of Autoimmune Diabetes: Evidence for the Modulation of Th17 Effector Cells via an IFNγ-Dependent Mechanism.

Authors:  Junu A George; Ghada Bashir; Mohammed M Qureshi; Yassir A Mohamed; Jamil Azzi; Basel K Al-Ramadi; Maria J Fernández-Cabezudo
Journal:  Front Immunol       Date:  2016-10-13       Impact factor: 7.561

6.  Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections.

Authors:  Christopher Nile; Monica Falleni; Daniela Cirasola; Abeer Alghamdi; Oliver F Anderson; Christopher Delaney; Gordon Ramage; Emerenziana Ottaviano; Delfina Tosi; Gaetano Bulfamante; Giulia Morace; Elisa Borghi
Journal:  mSphere       Date:  2019-01-23       Impact factor: 4.389

7.  Involvement of Acetylcholine Receptors in Cholinergic Pathway-Mediated Protection Against Autoimmune Diabetes.

Authors:  Maria J Fernández-Cabezudo; Junu A George; Ghada Bashir; Yassir A Mohamed; Alreem Al-Mansori; Mohammed M Qureshi; Dietrich E Lorke; Georg Petroianu; Basel K Al-Ramadi
Journal:  Front Immunol       Date:  2019-05-15       Impact factor: 7.561

8.  Perinatal exposure to insecticide methamidophos suppressed production of proinflammatory cytokines responding to virus infection in lung tissues in mice.

Authors:  Wataru Watanabe; Hiroki Yoshida; Akihiko Hirose; Toshi Akashi; Tomomi Takeshita; Nao Kuroki; Asami Shibata; Satoko Hongo; Seiko Hashiguchi; Katsuhiko Konno; Masahiko Kurokawa
Journal:  Biomed Res Int       Date:  2013-12-03       Impact factor: 3.411

9.  Cholinergic Activation Enhances Resistance to Oral Salmonella Infection by Modulating Innate Immune Defense Mechanisms at the Intestinal Barrier.

Authors:  Ray M Al-Barazie; Ghada Hassan Bashir; Mohammed M Qureshi; Yassir A Mohamed; Ashraf Al-Sbiei; Saeed Tariq; Wim J Lammers; Basel K Al-Ramadi; Maria J Fernandez-Cabezudo
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

Review 10.  Weaning stress and gastrointestinal barrier development: Implications for lifelong gut health in pigs.

Authors:  Adam J Moeser; Calvin S Pohl; Mrigendra Rajput
Journal:  Anim Nutr       Date:  2017-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.